IgA-nefropátia: vizsgálatok itt: Dél-Korea
12 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Where
- Seoul
- Életkor
- 2 év to 18 év
- People
- 28 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07498335 - 3. fázisTaking peopleA Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
- Where
- Seongnam-si, Seoul, Suwon, Yongin-si
- Életkor
- 18 év and over
- People
- 347 worldwide
- Run by
- Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00 - 2. fázisTaking peopleA Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Where
- Anyang-si, Seongnam-si, Seoul, Suwon
- Életkor
- 18 év to 60 év
- People
- 30 worldwide
- Run by
- Jade Biosciences, Inc.
See details and how to joinNCT07541287 - 2. fázisTaking peopleA Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07146906 · EU 2024-519699-24-00 - 2. fázisTaking peoplePhase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- Where
- Cheonan, Daegu, Gyeonggi-do, Seoul, Wŏnju
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06989359 - 3. fázisTaking peopleA Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Where
- Anyang-si, Busan, Seongnam-si, Seoul, Suwon
- Életkor
- 18 év and over
- People
- 454 worldwide
- Run by
- Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Bundang Gu, Busan, Cheongju-si, Seoul, Taegu
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 3. fázisTaking peopleOpen-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Where
- Cheonan, Guri-si, Seongnam-si, Seoul
- Életkor
- 18 év to 100 év
- People
- 220 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06858319 - 2. fázisTaking peopleStudy of WAL0921 in Patients With Glomerular Kidney Diseases
- Where
- Anyang, Busan, Seongnam-si, Seoul, Soeul, Suwon
- Életkor
- 18 év to 75 év
- People
- 96 worldwide
- Run by
- Walden Biosciences
See details and how to joinNCT06466135 - 3. fázisTaking peopleStudy of Ravulizumab in Pediatric Participants With Primary IgAN
- Where
- Seoul
- Életkor
- 2 év to 18 év
- People
- 36 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07024563 · EU 2024-520167-13-00 - 2/3. fázisCsak meghívásosTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
- Where
- Anyang, Busan, Daegu, Gwangju, Hwaseong-si, Seongnam, Seoul
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659 - No phaseTaking peopleKOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
- Where
- Chuncheon, Daegu, Seoul
- People
- 3000
- Run by
- Seoul National University Hospital
See details and how to joinNCT03929887